PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12421808-4	2003	Inhibition of the endogenous iPLA(2) activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels and reduces the final free arachidonic acid level after phenylephrine stimulation, without significant effect on the net increase in free arachidonic acid stimulated by phenylephrine.	Arachidonic Acid	94-110	phospholipase A2, group VI	Mus musculus	29-36	
12421808-4	2003	Inhibition of the endogenous iPLA(2) activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels and reduces the final free arachidonic acid level after phenylephrine stimulation, without significant effect on the net increase in free arachidonic acid stimulated by phenylephrine.	Arachidonic Acid	145-161	phospholipase A2, group VI	Mus musculus	29-36	
12421808-4	2003	Inhibition of the endogenous iPLA(2) activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels and reduces the final free arachidonic acid level after phenylephrine stimulation, without significant effect on the net increase in free arachidonic acid stimulated by phenylephrine.	Arachidonic Acid	145-161	phospholipase A2, group VI	Mus musculus	29-36	
12421808-8	2003	Our data provide the first evidence that iPLA(2) is required for maintaining basal free arachidonic acid levels and thus is essential for agonist-induced Ca(2+)-sensitization of contraction in vascular smooth muscle.	Arachidonic Acid	88-104	phospholipase A2, group VI	Mus musculus	41-48